| Pfizer | Current & Future Directions in CML | 4/23/2019 | Non-Limited | Research |
| Pfizer | Advances in the Management of Acute Leukemia | 4/25/2019 | Non-Limited | Research |
| Pfizer | Using Biosimilars in Oncology | 4/30/2019 | Non-Limited | Research |
| Pfizer | The Experimental Therapeutics Clinical Trials Network (UM1 Clinical Trial Required) | 5/13/2019 | Non-Limited | Research |
| NIH | Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) | 9/28/2019 | Non-Limited | Research |
| NIH | Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) | 9/28/2019 | Non-Limited | Research |
| NIH | Biology of Bladder Cancer (R01 Clinical Trial Optional) | 5/8/2022 | Non-Limited | Research |
| NIH | Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) | 1/8/2022 | Non-Limited | Research |
| NIH | Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required) | 1/4/2020 | Non-Limited | Research |
| NIH | Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional) | 1/8/2022 | Non-Limited | Research |
| NIH | Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional) | 1/8/2022 | Non-Limited | Research |
| NIH | Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) | 9/28/2019 | Non-Limited | Research |
| NIH | Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) | 9/28/2019 | Non-Limited | Research |
| NIH | Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional) | 8/4/2020 | Non-Limited | Research |
| NIH | Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) | 9/28/2019 | Non-Limited | Research |
| NIH | Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) | 9/28/2019 | Non-Limited | Research |
| NIH | Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) | 9/28/2019 | Non-Limited | Research |
| NIH | Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) | 9/28/2019 | Non-Limited | Research |
| NIH | Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) | 9/28/2019 | Non-Limited | Research |
| NIH | Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional) | 9/28/2019 | Non-Limited | Research |
| NIH | Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) | 9/28/2019 | Non-Limited | Research |
| NIH | https://ufresearch.infoready4.com/CompetitionSpace/#bulletinboardDetail/1783454 | 5/8/2022 | Non-Limited | Research |
| NIH | Biology of Bladder Cancer (R21 Clinical Trial Optional) | 5/8/2022 | Non-Limited | Research |
| NIH | Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) | 1/8/2022 | Non-Limited | Research |
| NIH | Summer Research Education Experience Program (R25 Clinical Trial Not Allowed) | 4/23/2019 | Non-Limited | Training/Career |
| NIH | Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) | 11/21/2019 | Non-Limited | Training/Career |
| NIH | Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) | 11/21/2019 | Non-Limited | Training/Career |
| NIH | Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required) | 1/4/2020 | Non-Limited | Research |
| NIH | Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional) | 1/8/2022 | Non-Limited | Research |
| NIH | End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional) | 1/8/2022 | Non-Limited | Training/Career |
| NIH | End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional) | 1/8/2019 | Non-Limited | Training/Career |
| NIH | Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) | 9/28/2019 | Non-Limited | Research |
| NIH | Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) | 6/18/2021 | Non-Limited | Research |
| NIH | Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional) | 1/8/2022 | Non-Limited | Research |
| NIH | Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) | 9/28/2019 | Non-Limited | Research |
| NIH | Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional) | 7/31/2020 | Non-Limited | Research |
| NIH | Advancing Cancer Immunotherapy by Mitigating Immune-Related Adverse Events (irAE) (U01 Clinical Trial Not Allowed) | 4/25/2019 | Non-Limited | Research |
| NIH | Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed) | 11/9/2021 | Non-Limited | Research |
| NIH | Microbial-based Cancer Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed) | 5/8/2022 | Non-Limited | Research |
| NIH | Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional) | 8/4/2020 | Non-Limited | Research |
| NIH | Optimizing the Management and Outcomes for Cancer Survivors Transitioning to Follow-up Care (R01 Clinical Trial Required) | 6/28/2019 | Non-Limited | Research |
| NIH | Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20 Clinical Trial Optional) | 10/19/2020 | Non-Limited | Training/Career |
| NIH | Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed) | 11/9/2021 | Non-Limited | Research |
| NIH | Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed) | 5/8/2022 | Non-Limited | Research |
| NIH | Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) | 9/28/2019 | Non-Limited | Research |
| NIH | Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) | 5/08/2021 | Non-Limited | Research |
| NIH | Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) | 11/21/2019 | Non-Limited | Research |
| DOD | Bone Marrow Failure Research Program: Idea Development Award | 6/6/2019 | Non-Limited | Research |
| DOD | Lung Cancer Research Program: Career Development Award | 8/1/2019 | Non-Limited | Research |
| DOD | Lung Cancer Research Program: Idea Development Award | 5/15/2019 | Non-Limited | Research |
| DOD | Lung Cancer Research Program: Investigator-Initiated Translational Research Award | 5/15/2019 | Non-Limited | Research |
| DOD | Lung Cancer Research Program: Translational Research Partnership Award | 5/15/2019 | Non-Limited | Research |
| DOD | Ovarian Cancer Research Program: Clinical Development Award | 4/30/2019 | Non-Limited | Research |
| DOD | Ovarian Cancer Research Program: Investigator-Initiated Research Award | 4/23/2019 | Non-Limited | Research |
| DOD | Ovarian Cancer Research Program: Ovarian Cancer Academy – Early-Career Investigator Award | 4/30/2019 | Non-Limited | Research |
| DOD | Ovarian Cancer Research Program: Pilot Award | 4/23/2019 | Non-Limited | Research |
| DOD | Peer Reviewed Cancer Research Program: Career Development Award | 8/21/2019 | Non-Limited | Research |
| DOD | Peer Reviewed Cancer Research Program: Horizon Award | 8/21/2019 | Non-Limited | Research |
| DOD | Peer Reviewed Cancer Research Program: Idea Award with Special Focus | 5/22/2019 | Non-Limited | Research |
| DOD | Peer Reviewed Cancer Research Program: Impact Award | 5/22/2019 | Non-Limited | Research |
| DOD | Peer Reviewed Cancer Research Program: Translational Team Science Award | 5/22/2019 | Non-Limited | Research |
| DOD | Prostate Cancer Research Program: Early Investigator Research Award | 6/6/2019 | Non-Limited | Research |
| DOD | Prostate Cancer Research Program: Physician Research Award | 6/6/2019 | Non-Limited | Research |
| DOD | Addressing Smoking Cessation in Clinical Practice | 5/9/2019 | Non-Limited | Research |
| CDC | Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients | 4/30/2019 | Non-Limited | Research |
| CDC | Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients | 4/30/2019 | Non-Limited | Research |
| CDC | Technical Assistance to Increase Tobacco Cessation | 5/13/2019 | Non-Limited | Research |
| NCI | Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) | 9/28/2019 | Non-Limited | Research |
| NCI | Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) | 9/28/2019 | Non-Limited | Research |
| NCI | Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) | 9/28/2019 | Non-Limited | Research |
| NCI | Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) | 9/28/2019 | Non-Limited | Research |
| NCI | The Experimental Therapeutics Clinical Trials Network (UM1 Clinical Trial Required) | 5/13/2019 | Limited | Research |
| NCI | The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratories (U24 Clinical Trial Not Allowed) | 5/13/2019 | Limited | Research |
| NCI | Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) | 9/28/2019 | Non-Limited | Research |
| NCI | Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional) | 9/28/2019 | Non-Limited | Research |
| Ovarian Cancer Research Program | Investigator-Initiated Research Award | 4/23/2019 | Non-Limited | Research |
| Ovarian Cancer Research Program | Pilot Award | 4/23/2019 | Non-Limited | Research |
| Ovarian Cancer Research Program | Clinical Development Award | 4/30/2019 | Non-Limited | Research |
| Ovarian Cancer Research Program | Ovarian Cancer Academy – Early-Career Investigator Award | 4/30/2019 | Non-Limited | Research |
| Ovarian Cancer Research Program | Ovarian Cancer Research Program | 5/31/2019 | Non-Limited | Research |
| Oncology Nursing Society Foundation | Oncology Nursing Research Grants | 8/15/2019 | Non-Limited | Research |
| Oncology Nursing Society Foundation | Oncology Nursing Research Grants | 8/15/2019 | Non-Limited | Research |
| Tell Every Amazing Lady About Ovarian Cancer | Ovarian Cancer Research Program | 5/31/2019 | Non-Limited | Research |
| Prostate Cancer Foundation | Prostate Cancer Foundation Challenge Awards For Metastatic, Lethal Prostate Cancer | 4/22/19 | Non-Limited | Research |
| Retirement Research Foundation | Grants for Projects in Aging | 5/1/2020 | Non-Limited | Research |
| Mark Foundation for Cancer Research | Emerging Leader Awards | 5/10/2019 | Non-Limited | Research |
| Prostate Cancer Foundation | PCF Challenge Awards For Metastatic, Lethal Prostate Cancer | 4/22/2019 | Non-Limited | Research |
| Ovarian Cancer Research Alliance | Liz Tilberis Early Career Award | 4/28/2019 | Non-Limited | Training/Career |
| Ovarian Cancer Research Alliance | Collaborative Research Development Grant | 4/28/2019 | Non-Limited | Training/Career |
| Ovarian Cancer Research Alliance | Ann and Sol Schreiber Mentored Investigator Award | 4/28/2019 | Non-Limited | Training/Career |
| Multiple Myeloma Research Foundation | Research Fellow Award | 6/24/2019 | Non-Limited | Training/Career |
